Live Breaking News & Updates on Ompugen ltd

Stay informed with the latest breaking news from Ompugen ltd on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ompugen ltd and stay connected to the pulse of your community

Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the appointment of Michelle Mahler, M.D., as Chief Medical Officer, effective March 1, 2024. Michelle will succeed Henry Adewoye, M.D., who is leaving Compugen to pursue other opportunities effective February 29, 2024, after 6 years with Compugen.

South-africa , Tel-aviv , Israel , Memorial-sloan-kettering-cancer-center , New-york , United-states , New-york-presbyterian-hospital , San-francisco , California , Yvonne-naughton , Weill-cornell , Nasdaq